Business: Health Care Industry

AG says Utah agrees to $24M Zyprexa settlement

AP - Wed Nov 11, 3:23 PM ET

SALT LAKE CITY - Utah has agreed to a $24 million settlement with Eli Lilly & Co. over claims the drugmaker engaged in off-label marketing of the anti-psychotic drug Zyprexa, Utah Attorney General Mark Shurtleff said Wednesday.

  • US soldiers attend a "Veterans Day" ceremony at Camp Eggers in Kabul. The number of US veterans who died in 2008 because they lacked health insurance was 14 times higher than the US military death toll in Afghanistan that year, according to a new study.(AFP/Massoud Hossaini)
    Lack of health care killed 2,266 US veterans last year: study AFP - Wed Nov 11, 1:06 PM ET

    WASHINGTON (AFP) - The number of US veterans who died in 2008 because they lacked health insurance was 14 times higher than the US military death toll in Afghanistan that year, according to a new study.

  • FILE - In this April 12, 2005 file photo, the world headquarters of Pfizer Inc. is shown in New York. In April, 2009, the FDA fired off warning letters to Pfizer Inc., GlaxoSmithKline and a dozen other drugmakers for search engine ads that violated federal rules. (AP Photo/Mark Lennihan, file)
    Drug industry presses FDA to allow more online ads AP - Wed Nov 11, 12:21 PM ET

    WASHINGTON - As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.

  • Emdeon 3Q loss widens on costs AP - Tue Nov 10, 6:50 PM ET

    ELMWOOD PARK, N.J. - Emdeon Corp., which provides financial and clinical services to the health care industry, said Tuesday its third-quarter loss widened on higher expenses and a boost in income tax costs.

  • CVS settles with NY over expired products AP - Tue Nov 10, 5:14 PM ET

    ALBANY, N.Y. - New York officials say they've reached an $875,000 settlement with CVS Pharmacy Inc. to stop sales of expired products — including food, medicine and baby formula.

  • Sanofi-Aventis, Regeneron extend development deal AP - Tue Nov 10, 5:11 PM ET

    NEW YORK - Sanofi-Aventis and Regeneron Pharmaceuticals Inc. said Tuesday they expanded an existing development partnership to run through 2017.

  • Teva gets FDA approval for generic Prevacid AP - Tue Nov 10, 4:42 PM ET

    NEW YORK - Teva Pharmaceutical Industries Ltd. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid.

  • Cumberland 3Q profit rose on Caldolor sales AP - Tue Nov 10, 12:17 PM ET

    NASHVILLE, Tenn. - Cumberland Pharmaceuticals Inc. said Tuesday its profit rose 6 percent in the third quarter, as sales of its recently approved fever and pain treatment Caldolor were partly offset by costs to launch the drug.

  • Wyo. Sen. Enzi critical of House health care bill AP - Tue Nov 10, 11:26 AM ET

    CHEYENNE, Wyo. - U.S. Sen. Mike Enzi says legislation passed by the U.S. House of Representatives would increase the cost of health insurance.

  • Acadia 3Q loss narrows on revenue boost AP - Mon Nov 9, 6:26 PM ET

    SAN DIEGO - Acadia Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on lower costs and a boost in revenue from its drug development partners.

  • A sign for Pharmaceutical company Pfizer is displayed on 42 Street in New York, seen here in October 2009. Pfizer announced Monday cuts in its research activities and staff after acquiring pharmaceutical rival Wyeth.(AFP/File/Timothy A. Clary)
    Pfizer slashes research, staff after Wyeth deal AFP - Mon Nov 9, 1:50 PM ET

    NEW YORK (AFP) - Pfizer announced Monday cuts in its research activities and staff after acquiring pharmaceutical rival Wyeth.

  • Enzon sells specialty drug business for $300M AP - Mon Nov 9, 11:18 AM ET

    BRIDGEWATER, N.J. - Enzon Pharmaceuticals Inc. said Monday it is selling most of its business to Italian drugmaker sigma-tau Group and will focus on its experimental cancer drugs and technologies.

  • Customers outside an Apotek Renen drug store in central Stockholm. Sweden sold 465 of its estimated 900 state-owned pharmacies to four firms for 5.9 billion kronor (572 million euros, 856 million dollars), authorities said Monday, ending a 36-year-old monopoly.(AFP/SCANPIX/File/Leif R Jansson)
    Auction ends Swedish pharmacy monopoly AFP - Mon Nov 9, 11:01 AM ET

    STOCKHOLM (AFP) - Sweden sold 465 of its estimated 900 state-owned pharmacies to four firms for 5.9 billion kronor (572 million euros, 856 million dollars), authorities said Monday, ending a 36-year-old monopoly.

  • Allianz makes Q3 net profit of euro1.32 billion AP - Mon Nov 9, 7:02 AM ET

    FRANKFURT - German insurer Allianz SE said Monday it posted a net profit in the third quarter from a loss a year ago due to improved revenue in life and health insurance and financial services.

  • Halozyme takes bigger loss on testing expenses AP - Fri Nov 6, 11:21 AM ET

    SAN DIEGO - Biotechnology company Halozyme Therapeutics Inc. reported a bigger third-quarter loss on Friday, as it started clinical trials of a fast-acting insulin during the period.

  • Threshold Pharmaceuticals 3Q loss widens on costs AP - Fri Nov 6, 10:43 AM ET

    REDWOOD CITY, Calif. - Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and interest expenses.

  • Health reform bill allows for Hawaii to opt out AP - Thu Nov 5, 9:53 PM ET

    HONOLULU - Hawaii would be allowed to opt out of key requirements of national health care reform legislation, the only state given such a privilege because it already has its own comprehensive health insurance law.

  • Health insurers weather storms heading into 2010 AP - Thu Nov 5, 6:22 PM ET

    INDIANAPOLIS - Rising unemployment, swine flu and the threat of health care reform all ganged up on managed care companies in the third quarter and could hurt their performance heading into 2010. But most of the large publicly traded health insurers reported better-than-expected profit growth for the latest period, and analysts still see strong core businesses beneath the challenges facing the industry.

  • FILE - In this Feb. 8, 2006 file photo, pedestrians walk past the headquarters of the health insurer Cigna Corp. in downtown Philadelphia. Managed care company Cigna Corp. said Thursday, Nov. 5, 2009, its third-quarter profit soared 92 percent, as improving equity markets spurred a big turnaround in a business segment that hurt the insurer last year.(AP Photo/Jacqueline Larma, File)
    Insurer Cigna's 3Q profit grows 92 percent AP - Thu Nov 5, 5:58 PM ET

    INDIANAPOLIS - Managed care company Cigna Corp.'s third-quarter profit soared 92 percent, as improving equity markets spurred a big turnaround in a discontinued business that hurt the insurer last year.

  • On the Call: Cigna President David Cordani AP - Thu Nov 5, 4:51 PM ET

    Health insurer WellPoint Inc. announced plans last spring to sell its pharmacy benefits management business to Express Scripts Inc. for about $4.68 billion. Analysts have wondered whether other managed care companies would consider a similar sale.

  • In this Nov. 3, 2009 photo, a CVS pharmacy sign is seen opposite the interior of one of the CVS locations, in Providence, R.I. CVS Caremark Corp. said Thursday, Nov. 5, 2009, its third-quarter profit jumped 39 percent on a boost from pharmacy benefits services and drugstore sales. (AP Photo/Steven Senne)
    CVS Caremark 3Q profit up but loses big contracts AP - Thu Nov 5, 4:49 PM ET

    NEW YORK - CVS Caremark disclosed more multibillion dollar contract losses in its pharmacy benefits management business and said the head of the unit will depart.

  • The US Capitol dome is seen in Washington, DC. The US House of Representatives was on course Wednesday to vote this weekend on sweeping legislation to overhaul US health care, President Barack Obama's top domestic priority, officials said.(AFP/File/Paul J. Richards)
    Democrats' plan to help 'uninsurables' questioned AP - Thu Nov 5, 10:46 AM ET

    WASHINGTON - You're afraid your cancer is back, and a health insurance company just turned you down.

  • King 3Q profit falls on charges, but tops forecast AP - Thu Nov 5, 10:43 AM ET

    BRISTOL, Tenn. - Drug developer King Pharmaceuticals said Thursday its third-quarter profit was cut in half by charges for related to its $1.6 billion buyout of rival Alpharma Inc.

  • BioCryst receives $22.5 million peramivir order AP - Thu Nov 5, 8:55 AM ET

    BIRMINGHAM, Ala. - BioCryst Pharmaceuticals Inc. said Thursday it will receive $22.5 million as part of a new contract with the Department of Health and Human Services over the intravenous flu treatment peramivir.

  • Cigna profit rises, beats forecasts Reuters - Thu Nov 5, 6:37 AM ET

    NEW YORK (Reuters) - Health insurer Cigna Corp posted higher third-quarter profit on Thursday as strength in stock market investments boosted the value of variable annuity products in its reinsurance business.

  • Acne, wrinkle treatments help Medicis post profit AP - Wed Nov 4, 6:21 PM ET

    SCOTTSDALE, Ariz. - Medicis Pharmaceutical Corp. posted a third-quarter profit on Wednesday, as sales of its skin products surged, and a research and development charge came off the books.

  • BioCryst partner seeks peramivir approval in Japan AP - Wed Nov 4, 1:49 PM ET

    BIRMINGHAM, Ala. - BioCryst Pharmaceuticals Inc. said Wednesday its partner Shionogi & Co. filed for approval to market BioCryst's IV flu drug peramivir in Japan.

  • Affymax 3Q loss narrows partnership payments AP - Wed Nov 4, 10:18 AM ET

    PALO ALTO, Calif. - Biotechnology company Affymax Inc. said Wednesday its third-quarter loss narrowed on a boost in payments from its partner Takeda Pharmaceutical on the anemia drug candidate Hematide.

  • Watson 3Q profit falls 11 percent on taxes, costs AP - Wed Nov 4, 9:50 AM ET

    MORRISTOWN, N.J. - Drug developer Watson Pharmaceuticals Inc. said Wednesday its profit fell 11 percent in the third quarter as higher taxes and charges offset a revenue boost.

  • HealthSouth raises outlook after 3Q profit jumps AP - Tue Nov 3, 6:45 PM ET

    BIRMINGHAM, Ala. - Inpatient rehabilitation services provider HealthSouth Corp. posted a greater third-quarter profit on Tuesday, and raised its expectations for the remainder of the year.

1  2  3  4  5    Next